Feature Channels: Personalized Medicine

Filters close
18-Nov-2024 8:00 AM EST
Females Heal More Quickly than Males after Muscle Injuries
American Physiological Society (APS)

Females may begin to recover twice as fast as males when it comes to muscle injuries, according to a new study in mice. The findings support the idea of forming individualized treatment plans based on a person’s biological sex. The research will be presented at the 2024 Integrative Physiology of Exercise conference, Nov. 20–22, in State College, Pennsylvania.

Released: 19-Nov-2024 10:10 AM EST
4 Things to Know About Lung Cancer Screening and Treatment
American College of Surgeons (ACS)

Lung cancer is responsible for approximately 1 in 4 cancer deaths in the United States, making it the deadliest cancer among Americans. However, early detection and advancements in treatment can significantly improve patient outcomes.

Released: 18-Nov-2024 8:35 AM EST
PharmassêtX Files Patent Application on New Form of Drug Substance from Green Tea
PharmassêtX Inc.

PharmassêtX Inc., a late-preclinical stage pharmaceutical development company, today announced that the US Patent and Trademark Office has acknowledged receipt of the Company's patent application entitled "CRYSTALLINE FORM OF EPIGALLOCATECHIN-3-GALLATE." PharmassêtX is developing the novel form of epigallocatechin gallate (EGCG) as a prescription drug for the treatment of inflammatory bowel disease (IBD).

Not for public release

This news release is embargoed until 16-Nov-2024 2:30 PM EST Released to reporters: 14-Nov-2024 11:00 AM EST

A reporter's PressPass is required to access this story until the embargo expires on 16-Nov-2024 2:30 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 31-Oct-2024 8:25 AM EDT
$75 Million Donation From AbbVie Foundation to Support UChicago Medicine’s New Cancer Pavilion
University of Chicago Medical Center

The AbbVie Foundation, a nonprofit working to advance health equity, is donating $75 million to UChicago Medicine to support the $815 million cost to construct a state-of-the-art cancer care pavilion, the first and only freestanding facility of its kind in Illinois.

Newswise: Danforth Technology Company Launches New Startup
Released: 28-Oct-2024 9:30 AM EDT
Danforth Technology Company Launches New Startup
Donald Danforth Plant Science Center

The Danforth Technology Company (DTC) today announced the launch of Metablify, a startup that has developed a breakthrough technology platform that enables the detection and quantification of previously undetectable metabolites and chemicals in large numbers of biological samples processed using LC/MS data processing algorithms.

Newswise: 100724_banner.png
Released: 17-Oct-2024 12:10 PM EDT
Fine-Tuning the Tools That Enhance Reproducibility
SLAS

Fine-tuning the Tools that Enhance Reproducibility

Newswise: Researchers Help Redefine Core Microbiome, Opening New Chapter in Precision Health
Released: 16-Oct-2024 12:25 PM EDT
Researchers Help Redefine Core Microbiome, Opening New Chapter in Precision Health
Rutgers University-New Brunswick

Researchers at Rutgers University-New Brunswick, along with international collaborators, have introduced a novel method for identifying the crucial set of gut microbes commonly found in humans and essential for health.

Newswise: Nipple-Sparing Mastectomy: A Modern Approach to Breast Cancer Surgery
Released: 11-Oct-2024 1:05 PM EDT
Nipple-Sparing Mastectomy: A Modern Approach to Breast Cancer Surgery
Rutgers Cancer Institute

Nipple-Sparing Mastectomy (NSM) is a surgical option for patients requiring a mastectomy, in which the breast tissue is removed while the skin, nipple, and areola remain intact. This procedure allows for immediate reconstruction and offers a more natural post-surgery result, giving patients both peace of mind and a sense of body confidence. M. Michele Blackwood, MD, FACS, director of Breast Surgery and director of Women’s Oncologic Health, RWJBarnabas Health and Rutgers Cancer Institute shares more on this surgical technique.

Newswise: UNC Fast-Tracks Personalized Treatment for Twins with Ultra Rare Genetic Disorder
Released: 26-Sep-2024 11:05 AM EDT
UNC Fast-Tracks Personalized Treatment for Twins with Ultra Rare Genetic Disorder
University of North Carolina School of Medicine

At 7-years-old, Amelia and Makenzie Kahn were diagnosed with juvenile Batten disease, an extremely rare and progressively fatal genetic disorder. Instead of giving in to the disease, the Kahn family searched for a treatment.

Newswise: Organoids Derived From Gut Stem Cells Reveal Two Distinct Molecular Subtypes of Crohn’s Disease
25-Sep-2024 8:05 PM EDT
Organoids Derived From Gut Stem Cells Reveal Two Distinct Molecular Subtypes of Crohn’s Disease
University of California San Diego

UC San Diego researchers discover two distinct molecular subtypes of Crohn’s disease using patient-derived organoids, opening the door to personalized treatment for the chronic inflammatory bowel disease.

13-Sep-2024 9:45 AM EDT
ESMO: Combination Therapy Reduced Agitated Delirium in Patients with Advanced Cancers
University of Texas MD Anderson Cancer Center

Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with advanced cancers, compared with haloperidol alone, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center.

Newswise: Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD
Released: 6-Sep-2024 12:20 PM EDT
Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD
Cancer Research Institute

CRI is co-hosting CICON24 to illuminate pioneering advances in cancer immunotherapy research starting September 8 in National Harbor, MD.

Newswise: ARPA-H project to pioneer rapid manufacturing of tumor models
Released: 20-Aug-2024 1:05 PM EDT
ARPA-H project to pioneer rapid manufacturing of tumor models
University Of Illinois Grainger College Of Engineering

Advanced imaging and AI will power the manufacture of any cancer at the push of a button.

   
Newswise: Targeting cancer with precision: neoantigen vaccines show promise
Released: 19-Aug-2024 7:05 AM EDT
Targeting cancer with precision: neoantigen vaccines show promise
Chinese Academy of Sciences

In an elegant fusion of science and medicine, neoantigen cancer vaccines are emerging as a formidable strategy in the battle against cancer. These vaccines, a testament to the power of personalized medicine, target cancer's unique protein signatures, rallying the immune system for a precise and potent attack.

Newswise: Decoding calcifications in breast cancer: towards personalized medicine
Released: 13-Aug-2024 10:05 AM EDT
Decoding calcifications in breast cancer: towards personalized medicine
Chinese Academy of Sciences

A pivotal study uncovers the molecular signatures of mammographic calcifications in hormone receptor-positive, HER2-negative breast cancer.

Released: 13-Aug-2024 8:05 AM EDT
Advancing the battle against Hodgkin's lymphoma: new treatment insights
Chinese Academy of Sciences

In a notable advancement for Hodgkin's lymphoma (HL), recent research has introduced sophisticated therapeutic strategies designed to significantly boost patient outcomes.

Newswise: Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia
Released: 5-Aug-2024 5:05 PM EDT
Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia
St. Jude Children's Research Hospital

Explore how scientists at St. Jude Children’s Research Hospital have identified causes for age-related differences in treatment outcomes of B-cell acute lymphoblastic leukemia.

24-Jul-2024 12:00 PM EDT
The consequences of ending abortion protection, the patient perspective on laboratory developed tests, health equity, and more to be explored at ADLM 2024
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

At ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) in Chicago, more than 300 experts will present cutting-edge research and technology that will shape the future of laboratory medicine and improve patient care.

Newswise: Study Identifies Biomarker that Could Predict Whether Colon Cancer Patients Benefit from Chemotherapy
Released: 26-Jul-2024 4:05 PM EDT
Study Identifies Biomarker that Could Predict Whether Colon Cancer Patients Benefit from Chemotherapy
Sylvester Comprehensive Cancer Center

A new study identifies and validates a 10-gene biomarker that potentially predicts whether a stage II or III colon cancer patient will benefit from adjuvant chemotherapy. A secondary finding from the study suggests that the gene signature could potentially also predict whether immunotherapy would help some patients.



close
2.17911